Guillermo Caceres-Cardenas
Dados Biográficos
| ID | 9067725 |
|---|---|
| NOME | Guillermo Caceres-Cardenas |
| PRENOMES | Guillermo |
| SOBRENOME | Caceres-Cardenas |
| ASSINATURA | CACERES-CARDENAS G |
| AFILIAÇÕES | Universidad Peruana Cayetano Heredia |
| ORCID | 0000-0003-1447-5608 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2023 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Fighting tuberculosis hand in hand
Tuberculosis (TB) is an infectious disease closely intertwined with stigma, discrimination, and the social determinants of health. Communities of people affected by TB are experts in their care pathways, but the TB field continues to fall short of meaningfully engaging communities in TB research. This is a missed opportunity to improve the quality, relevance, person-centeredness, positive impact, and sustainability of TB research outputs. We ackn…
Original article
Objectives: The COVID-19 pandemic caused a global shortage of nasopharyngeal (NP) swabs, required for RT-PCR testing. Canadian manufacturers were contacted to share NP swab innovations. The primary objective was to determine whether novel NP test swabs were comparable to commercially available swabs regarding user characteristics, ability to collect a specimen, and diagnostic performance using RT-PCR testing. Methods: Participants were randomized…
Diagnostic performance of four lateral flow immunoassays for Covid-19 antibodies in Peruvian population
Serological assays have been used in seroprevalence studies to inform the dynamics of COVID-19. Lateral flow immunoassay (LFIA) tests are a very practical technology to use for this objective; however, one of their challenges may be variable diagnostic performance. Given the numerous available LFIA tests, evaluation of their accuracy is critical before real-world implementation. We performed a retrospective diagnostic evaluation study to independ…
Sem obras proeminentes nesta página.
Diagnostic performance of four lateral flow immunoassays for Covid-19 antibodies in Peruvian population
Serological assays have been used in seroprevalence studies to inform the dynamics of COVID-19. Lateral flow immunoassay (LFIA) tests are a very practical technology to use for this objective; however, one of their challenges may be variable diagnostic performance. Given the numerous available LFIA tests, evaluation of their accuracy is critical before real-world implementation. We performed a retrospective diagnostic evaluation study to independ…
Original article
Objectives: The COVID-19 pandemic caused a global shortage of nasopharyngeal (NP) swabs, required for RT-PCR testing. Canadian manufacturers were contacted to share NP swab innovations. The primary objective was to determine whether novel NP test swabs were comparable to commercially available swabs regarding user characteristics, ability to collect a specimen, and diagnostic performance using RT-PCR testing. Methods: Participants were randomized…
Fighting tuberculosis hand in hand
Tuberculosis (TB) is an infectious disease closely intertwined with stigma, discrimination, and the social determinants of health. Communities of people affected by TB are experts in their care pathways, but the TB field continues to fall short of meaningfully engaging communities in TB research. This is a missed opportunity to improve the quality, relevance, person-centeredness, positive impact, and sustainability of TB research outputs. We ackn…
Medicine (3 obras) · Disease (2 obras) · Psychology (2 obras) · SARS-CoV-2 detection and testing (2 obras) · Virology (2 obras) · 2019-20 coronavirus outbreak (1 obras) · Antibody (1 obras) · Biosensors and Analytical Detection (1 obras) · Community engagement (1 obras) · COVID-19 Clinical Research Studies (1 obras)